MEDIVIS

Company profile

About MEDIVIS

Medivis is a medical technology company founded in 2016 by physicians and engineers in New York City, specializing in augmented reality and artificial intelligence for surgical care. The company's flagship product, Medivis Studio, is an FDA-cleared, CE-marked imaging platform that transforms pre-operative medical imaging into surgical plans and integrates with devices throughout the operating room. Available on Windows and macOS, Studio handles CT, MRI, ultrasound, fluoroscopy, and PET imaging, offering automatic segmentation, trajectory planning, and real-time 3D rendering. Medivis has secured three FDA clearances for its surgical navigation systems: Spine Navigation for open and minimally invasive cases, Cranial Navigation for catheters, shunts and craniotomies, and Body Navigation (clearance pending) with prostate biopsy as the lead indication. The platform supports deployment via proprietary AR loupes and commercial head-mounted displays from Meta, Apple, and Microsoft, as well as spatial monitors and tracked ultrasound probes. The company's Frontier research division is developing Maia, a contextual harness for vision-language models, and exploring robotic autonomy within the navigation loop. Medivis serves surgeons, health systems, and ASCs, with a mission to make augmented reality and artificial intelligence the standard of surgical care by empowering clinicians with real-time information for precise decision-making.

Company description · MEDIVIS official website

Mission. Making augmented reality and artificial intelligence the standard of surgical care: the plan built on the patient's own imaging, then carried into the operating room and placed on the patient, in the surgeon's view.